Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Significant Growth in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 222,900 shares, a growth of 747.5% from the November 30th total of 26,300 shares. Based on an average daily volume of 1,352,700 shares, the days-to-cover ratio is currently 0.2 days.

Ono Pharmaceutical Price Performance

Shares of OPHLY stock traded down $0.05 during trading hours on Thursday, reaching $3.36. The company had a trading volume of 757,296 shares, compared to its average volume of 239,843. Ono Pharmaceutical has a 12-month low of $3.27 and a 12-month high of $6.11. The stock has a fifty day moving average of $3.89 and a 200-day moving average of $4.38.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.